ArticleBreast cancer research and treatment2015

The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells.

Jillian E Koziel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.